These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32318720)
1. Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term. Lopez-Santalla M; Hervas-Salcedo R; Fernandez-Garcia M; Bueren JA; Garin MI J Crohns Colitis; 2020 Oct; 14(10):1424-1435. PubMed ID: 32318720 [TBL] [Abstract][Full Text] [Related]
2. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis. Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774 [TBL] [Abstract][Full Text] [Related]
3. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu. Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS Front Immunol; 2018; 9():1078. PubMed ID: 29892282 [TBL] [Abstract][Full Text] [Related]
4. Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Dextran Sulfate Sodium-Induced Severe Colitis in Rats. Onishi R; Ohnishi S; Higashi R; Watari M; Yamahara K; Okubo N; Nakagawa K; Katsurada T; Suda G; Natsuizaka M; Takeda H; Sakamoto N Cell Transplant; 2015; 24(12):2601-14. PubMed ID: 25812083 [TBL] [Abstract][Full Text] [Related]
5. Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells. Kawata Y; Tsuchiya A; Seino S; Watanabe Y; Kojima Y; Ikarashi S; Tominaga K; Yokoyama J; Yamagiwa S; Terai S Cell Tissue Res; 2019 May; 376(2):257-271. PubMed ID: 30635774 [TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. Heidari M; Pouya S; Baghaei K; Aghdaei HA; Namaki S; Zali MR; Hashemi SM J Cell Physiol; 2018 Nov; 233(11):8754-8766. PubMed ID: 29797577 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-Induced Murine Chronic Colitis. Lee HJ; Oh SH; Jang HW; Kwon JH; Lee KJ; Kim CH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH Gut Liver; 2016 May; 10(3):412-9. PubMed ID: 27114436 [TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis. Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970 [TBL] [Abstract][Full Text] [Related]
9. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice. Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461 [TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells. Nikolic A; Simovic Markovic B; Gazdic M; Randall Harrell C; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; L Lukic M; Stojkovic M; Volarevic V Biomed Pharmacother; 2018 Apr; 100():426-432. PubMed ID: 29471245 [TBL] [Abstract][Full Text] [Related]
11. A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis. Alves VBF; de Sousa BC; Fonseca MTC; Ogata H; Caliári-Oliveira C; Yaochite JNU; Rodrigues Júnior V; Chica JEL; da Silva JS; Malmegrim KCR; Pernomian L; Cardoso CR Clin Exp Immunol; 2019 May; 196(2):139-154. PubMed ID: 30663040 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743 [TBL] [Abstract][Full Text] [Related]
13. Dextran sulphate sodium increases splenic Gr1(+)CD11b(+) cells which accelerate recovery from colitis following intravenous transplantation. Zhang R; Ito S; Nishio N; Cheng Z; Suzuki H; Isobe KI Clin Exp Immunol; 2011 Jun; 164(3):417-27. PubMed ID: 21413942 [TBL] [Abstract][Full Text] [Related]
14. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice. Xu J; Wang X; Chen J; Chen S; Li Z; Liu H; Bai Y; Zhi F Theranostics; 2020; 10(26):12204-12222. PubMed ID: 33204338 [No Abstract] [Full Text] [Related]
15. Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat. Tanaka H; Arimura Y; Yabana T; Goto A; Hosokawa M; Nagaishi K; Yamashita K; Yamamoto H; Sasaki Y; Fujimiya M; Imai K; Shinomura Y J Gastroenterol; 2011 Feb; 46(2):143-52. PubMed ID: 20848145 [TBL] [Abstract][Full Text] [Related]
16. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790 [TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens. Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model. Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200 [TBL] [Abstract][Full Text] [Related]
19. Immortalized Canine Adipose-Derived Mesenchymal Stem Cells Maintain the Immunomodulatory Capacity of the Original Primary Cells. Yasumura Y; Teshima T; Nagashima T; Michishita M; Takano T; Taira Y; Suzuki R; Matsumoto H Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139314 [TBL] [Abstract][Full Text] [Related]
20. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice. Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]